Improving Peptide Receptor Radionuclide Therapy with PARP inhibitors

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513007-14-00

Acronym

NL79259.078.21

Enrollment

Registered

2024-05-28

Start date

2022-03-24

Completion date

Unknown

Last updated

2024-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

locally advanced or metastatic, well-differentiated gastro-enteropancreatic neuroendocrine tumors.

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026